BioengineeringbioRxiv
CRISPR-Cas9 modified bacteriophage for treatment of Staphylococcus aureus induced osteomyelitis and soft tissue infection
L. K. Horstemeyer, J. Park, E. A. Swanson…·L. B. Priddy
This study evaluates CRISPR-Cas9 modified bacteriophages for treating Staphylococcus aureus infections in vitro and in a rat osteomyelitis model, showing efficacy against biofilm and soft tissue infection.
DOI 10.1371/journal.pone.0220421